Literature DB >> 15147340

Interleukin-18 as a potential target in inflammatory arthritis.

J A Gracie1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15147340      PMCID： PMC1809042          DOI： 10.1111/j.1365-2249.2004.02475.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN： 0009-9104            Impact factor:   4.330


× No keyword cloud information.
  37 in total

1.  IL-18 is a potent coinducer of IL-13 in NK and T cells: a new potential role for IL-18 in modulating the immune response.

Authors:  T Hoshino; R H Wiltrout; H A Young
Journal:  J Immunol       Date:  1999-05-01       Impact factor: 5.422

2.  A role for IL-18 in neutrophil activation.

Authors:  B P Leung; S Culshaw; J A Gracie; D Hunter; C A Canetti; C Campbell; F Cunha; F Y Liew; I B McInnes
Journal:  J Immunol       Date:  2001-09-01       Impact factor: 5.422

3.  IL-18 augments perforin-dependent cytotoxicity of liver NK-T cells.

Authors:  T Dao; W Z Mehal; I N Crispe
Journal:  J Immunol       Date:  1998-09-01       Impact factor: 5.422

4.  Therapeutic effect of neutralizing endogenous IL-18 activity in the collagen-induced model of arthritis.

Authors:  C Plater-Zyberk; L A Joosten; M M Helsen; P Sattonnet-Roche; C Siegfried; S Alouani; F A van De Loo; P Graber; S Aloni; R Cirillo; E Lubberts; C A Dinarello; W B van Den Berg; Y Chvatchko
Journal:  J Clin Invest       Date:  2001-12       Impact factor: 14.808

5.  ATP-stimulated release of interleukin (IL)-1beta and IL-18 requires priming by lipopolysaccharide and is independent of caspase-1 cleavage.

Authors:  V B Mehta; J Hart; M D Wewers
Journal:  J Biol Chem       Date:  2000-10-30       Impact factor: 5.157

6.  A proinflammatory role for IL-18 in rheumatoid arthritis.

Authors:  J A Gracie; R J Forsey; W L Chan; A Gilmour; B P Leung; M R Greer; K Kennedy; R Carter; X Q Wei; D Xu; M Field; A Foulis; F Y Liew; I B McInnes
Journal:  J Clin Invest       Date:  1999-11       Impact factor: 14.808

7.  IL-1H, an interleukin 1-related protein that binds IL-18 receptor/IL-1Rrp.

Authors:  G Pan; P Risser; W Mao; D T Baldwin; A W Zhong; E Filvaroff; D Yansura; L Lewis; C Eigenbrot; W J Henzel; R Vandlen
Journal:  Cytokine       Date:  2001-01-07       Impact factor: 3.861

8.  Combined effects of IL-12 and IL-18 on the induction of collagen-induced arthritis.

Authors:  B P Leung; I B McInnes; E Esfandiari; X Q Wei; F Y Liew
Journal:  J Immunol       Date:  2000-06-15       Impact factor: 5.422

9.  Activation of interferon-gamma inducing factor mediated by interleukin-1beta converting enzyme.

Authors:  Y Gu; K Kuida; H Tsutsui; G Ku; K Hsiao; M A Fleming; N Hayashi; K Higashino; H Okamura; K Nakanishi; M Kurimoto; T Tanimoto; R A Flavell; V Sato; M W Harding; D J Livingston; M S Su
Journal:  Science       Date:  1997-01-10       Impact factor: 47.728

10.  Signal transduction pathways involved in rheumatoid arthritis synovial fibroblast interleukin-18-induced vascular cell adhesion molecule-1 expression.

Authors:  Jacques C M Morel; Christy C Park; Kui Zhu; Pawan Kumar; Jeffrey H Ruth; Alisa E Koch
Journal:  J Biol Chem       Date:  2002-07-08       Impact factor: 5.157
View more
  16 in total

1.  IL-18 mediates proapoptotic signaling in renal tubular cells through a Fas ligand-dependent mechanism.

Authors:  Hongji Zhang; Karen L Hile; Hiroshi Asanuma; Brian Vanderbrink; Ethan I Franke; Matthew T Campbell; Kirstan K Meldrum
Journal:  Am J Physiol Renal Physiol       Date:  2011-04-20

2.  Synovial proinflammatory cytokines and their correlation with matrix metalloproteinase-3 expression in Behçet's disease. Does interleukin-1beta play a major role in Behçet's synovitis?

Authors:  Salih Pay; Hakan Erdem; Aysel Pekel; Ismail Simsek; Ugur Musabak; Ali Sengul; Ayhan Dinc
Journal:  Rheumatol Int       Date:  2005-10-05       Impact factor: 2.631

Review 3.  The role of inflammasome in Alzheimer's disease.

Authors:  Li Liu; Christina Chan
Journal:  Ageing Res Rev       Date:  2014-02-19       Impact factor: 10.895

4.  Elevated urinary IL-18 levels at the time of ICU admission predict adverse clinical outcomes.

Authors:  Edward D Siew; T Alp Ikizler; Tebeb Gebretsadik; Ayumi Shintani; Nancy Wickersham; Frederick Bossert; Josh F Peterson; Chirag R Parikh; Addison K May; Lorraine B Ware
Journal:  Clin J Am Soc Nephrol       Date:  2010-06-17       Impact factor: 8.237

Review 5.  Interleukin 18 in the CNS.

Authors:  Silvia Alboni; Davide Cervia; Shuei Sugama; Bruno Conti
Journal:  J Neuroinflammation       Date:  2010-01-29       Impact factor: 8.322

6.  MyD88 deficiency results in tissue-specific changes in cytokine induction and inflammation in interleukin-18-independent mice infected with Borrelia burgdorferi.

Authors:  Aruna K Behera; Ethan Hildebrand; Roderick T Bronson; George Perides; Satoshi Uematsu; Shizuo Akira; Linden T Hu
Journal:  Infect Immun       Date:  2006-03       Impact factor: 3.441

7.  Interleukin-18 as a mediator of systemic juvenile idiopathic arthritis.

Authors:  Marija Jelusić; Ivan Kresimir Lukić; Lana Tambić-Bukovac; Klara Dubravcić; Ivan Malcić; Igor Rudan; Drago Batinić
Journal:  Clin Rheumatol       Date:  2006-11-25       Impact factor: 2.980

8.  Expression of interleukin-18, IL-18BP, and IL-18R in serum, synovial fluid, and synovial tissue in patients with rheumatoid arthritis.

Authors:  Xue-Ting Shao; Lei Feng; Li-Juan Gu; Li-Juan Wu; Ting-Ting Feng; Yun-Mei Yang; Nan-Ping Wu; Hang-Ping Yao
Journal:  Clin Exp Med       Date:  2009-02-19       Impact factor: 3.984

9.  Urine Injury Biomarkers and Risk of Adverse Outcomes in Recipients of Prevalent Kidney Transplants: The Folic Acid for Vascular Outcome Reduction in Transplantation Trial.

Authors:  Nisha Bansal; Myra A Carpenter; Daniel E Weiner; Andrew S Levey; Marc Pfeffer; John W Kusek; Jianwen Cai; Lawrence G Hunsicker; Meyeon Park; Michael Bennett; Kathleen D Liu; Chi-Yuan Hsu
Journal:  J Am Soc Nephrol       Date:  2015-11-04       Impact factor: 10.121

10.  Anti-inflammatory effect of pigment epithelium-derived factor in DBA/2J mice.

Authors:  Xiaohong Zhou; Feng Li; Li Kong; James Chodosh; Wei Cao
Journal:  Mol Vis       Date:  2009-02-27       Impact factor: 2.367
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.